|
gptkb:Section_501(c)(6)
|
net earnings to benefit any private shareholder or individual
|
|
gptkb:gap_junction
|
passage of large molecules
|
|
gptkb:501(c)(2)
|
Operation of unrelated business
|
|
gptkb:B-1/B-2_tourist_visa
|
employment
|
|
gptkb:FIA_Grade_2
|
Formula One races
|
|
gptkb:Gap_Junction
|
Passage of large proteins
|
|
gptkb:PriorityQueue_class
|
null elements
|
|
gptkb:FDA_(for_investigational_use)
|
commercial distribution
|
|
gptkb:Non-aggression_Principle
|
gptkb:fraud
|
|
gptkb:Non-aggression_Principle
|
gptkb:crime
|
|
gptkb:501(c)(2)
|
Charitable activities directly
|
|
gptkb:Part_15_(Radio_Frequency_Devices)
|
protection from interference for Part 15 devices
|
|
gptkb:Gap_Junction
|
Passage of nucleic acids
|
|
gptkb:United_States_(with_ESTA)
|
Study
|
|
gptkb:B-1/B-2_tourist_visa
|
gptkb:academic
|
|
gptkb:F-1_Visa
|
permanent employment
|
|
gptkb:United_States_(with_ESTA)
|
Work
|
|
gptkb:Category_B_licence
|
large goods vehicles
|
|
gptkb:Non-aggression_Principle
|
initiation of force
|
|
gptkb:Section_457(b)
|
employer matching contributions for tax-exempt organizations
|